Attenuation of Vanadium-Induced Neurotoxicity in Rat Hippocampal Slices (In Vitro) and Mice (In Vivo) by ZA-II-05, a Novel NMDA-Receptor Antagonist

Exposure to heavy metals, such as vanadium, poses an ongoing environmental and health threat, heightening the risk of neurodegenerative disorders. While several compounds have shown promise in mitigating vanadium toxicity, their efficacy is limited. Effective strategies involve targeting specific su...

Full description

Bibliographic Details
Main Authors: Amany Digal Ladagu, Funmilayo Eniola Olopade, Paul Chazot, Ademola A. Oyagbemi, Samuel Ohiomokhare, Oluwabusayo Racheal Folarin, Taidinda Tashara Gilbert, Madison Fuller, Toan Luong, Adeboye Adejare, James O. Olopade
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/23/16710
_version_ 1797400148190429184
author Amany Digal Ladagu
Funmilayo Eniola Olopade
Paul Chazot
Ademola A. Oyagbemi
Samuel Ohiomokhare
Oluwabusayo Racheal Folarin
Taidinda Tashara Gilbert
Madison Fuller
Toan Luong
Adeboye Adejare
James O. Olopade
author_facet Amany Digal Ladagu
Funmilayo Eniola Olopade
Paul Chazot
Ademola A. Oyagbemi
Samuel Ohiomokhare
Oluwabusayo Racheal Folarin
Taidinda Tashara Gilbert
Madison Fuller
Toan Luong
Adeboye Adejare
James O. Olopade
author_sort Amany Digal Ladagu
collection DOAJ
description Exposure to heavy metals, such as vanadium, poses an ongoing environmental and health threat, heightening the risk of neurodegenerative disorders. While several compounds have shown promise in mitigating vanadium toxicity, their efficacy is limited. Effective strategies involve targeting specific subunits of the NMDA receptor, a glutamate receptor linked to neurodegenerative conditions. The potential neuroprotective effects of ZA-II-05, an NMDA receptor antagonist, against vanadium-induced neurotoxicity were explored in this study. Organotypic rat hippocampal slices, and live mice, were used as models to comprehensively evaluate the compound’s impact. Targeted in vivo fluorescence analyses of the hippocampal slices using propidium iodide as a marker for cell death was utilized. The in vivo study involved five dams, each with eight pups, which were randomly assigned to five experimental groups (<i>n</i> = 8 pups). After administering treatments intraperitoneally over six months, various brain regions were assessed for neuropathologies using different immunohistochemical markers. High fluorescence intensity was observed in the hippocampal slices treated with vanadium, signifying cell death. Vanadium-exposed mice exhibited demyelination, microgliosis, and neuronal cell loss. Significantly, treatment with ZA-II-05 resulted in reduced cellular death in the rat hippocampal slices and preserved cellular integrity and morphological architecture in different anatomical regions, suggesting its potential in countering vanadium-induced neurotoxicity.
first_indexed 2024-03-09T01:50:20Z
format Article
id doaj.art-e470fd4256d14a10b2388685f7a0cd61
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T01:50:20Z
publishDate 2023-11-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-e470fd4256d14a10b2388685f7a0cd612023-12-08T15:16:51ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-11-0124231671010.3390/ijms242316710Attenuation of Vanadium-Induced Neurotoxicity in Rat Hippocampal Slices (In Vitro) and Mice (In Vivo) by ZA-II-05, a Novel NMDA-Receptor AntagonistAmany Digal Ladagu0Funmilayo Eniola Olopade1Paul Chazot2Ademola A. Oyagbemi3Samuel Ohiomokhare4Oluwabusayo Racheal Folarin5Taidinda Tashara Gilbert6Madison Fuller7Toan Luong8Adeboye Adejare9James O. Olopade10Department of Veterinary Anatomy, University of Ibadan, Ibadan 200284, NigeriaDepartment of Anatomy, College of Medicine, University of Ibadan, Ibadan 200284, NigeriaDepartment of Biosciences, Durham University, County Durham DH1 3LE, UKDepartment of Veterinary Physiology and Biochemistry, Faculty of Veterinary Medicine, University of Ibadan, Ibadan 200284, NigeriaDepartment of Biosciences, Durham University, County Durham DH1 3LE, UKDepartment of Veterinary Anatomy, University of Ibadan, Ibadan 200284, NigeriaDepartment of Veterinary Anatomy, University of Ibadan, Ibadan 200284, NigeriaDepartment of Neuroscience, College of Arts and Sciences, Saint Joseph’s University, Philadelphia, PA 19131, USADepartment of Neuroscience, College of Arts and Sciences, Saint Joseph’s University, Philadelphia, PA 19131, USADepartment of Pharmaceutical Sciences, Philadelphia College of Pharmacy, Saint Joseph’s University, Philadelphia, PA 19131, USADepartment of Veterinary Anatomy, University of Ibadan, Ibadan 200284, NigeriaExposure to heavy metals, such as vanadium, poses an ongoing environmental and health threat, heightening the risk of neurodegenerative disorders. While several compounds have shown promise in mitigating vanadium toxicity, their efficacy is limited. Effective strategies involve targeting specific subunits of the NMDA receptor, a glutamate receptor linked to neurodegenerative conditions. The potential neuroprotective effects of ZA-II-05, an NMDA receptor antagonist, against vanadium-induced neurotoxicity were explored in this study. Organotypic rat hippocampal slices, and live mice, were used as models to comprehensively evaluate the compound’s impact. Targeted in vivo fluorescence analyses of the hippocampal slices using propidium iodide as a marker for cell death was utilized. The in vivo study involved five dams, each with eight pups, which were randomly assigned to five experimental groups (<i>n</i> = 8 pups). After administering treatments intraperitoneally over six months, various brain regions were assessed for neuropathologies using different immunohistochemical markers. High fluorescence intensity was observed in the hippocampal slices treated with vanadium, signifying cell death. Vanadium-exposed mice exhibited demyelination, microgliosis, and neuronal cell loss. Significantly, treatment with ZA-II-05 resulted in reduced cellular death in the rat hippocampal slices and preserved cellular integrity and morphological architecture in different anatomical regions, suggesting its potential in countering vanadium-induced neurotoxicity.https://www.mdpi.com/1422-0067/24/23/16710Alzheimer’s diseasevanadiumNMDA-receptor antagonistneurotoxicityhippocampus
spellingShingle Amany Digal Ladagu
Funmilayo Eniola Olopade
Paul Chazot
Ademola A. Oyagbemi
Samuel Ohiomokhare
Oluwabusayo Racheal Folarin
Taidinda Tashara Gilbert
Madison Fuller
Toan Luong
Adeboye Adejare
James O. Olopade
Attenuation of Vanadium-Induced Neurotoxicity in Rat Hippocampal Slices (In Vitro) and Mice (In Vivo) by ZA-II-05, a Novel NMDA-Receptor Antagonist
International Journal of Molecular Sciences
Alzheimer’s disease
vanadium
NMDA-receptor antagonist
neurotoxicity
hippocampus
title Attenuation of Vanadium-Induced Neurotoxicity in Rat Hippocampal Slices (In Vitro) and Mice (In Vivo) by ZA-II-05, a Novel NMDA-Receptor Antagonist
title_full Attenuation of Vanadium-Induced Neurotoxicity in Rat Hippocampal Slices (In Vitro) and Mice (In Vivo) by ZA-II-05, a Novel NMDA-Receptor Antagonist
title_fullStr Attenuation of Vanadium-Induced Neurotoxicity in Rat Hippocampal Slices (In Vitro) and Mice (In Vivo) by ZA-II-05, a Novel NMDA-Receptor Antagonist
title_full_unstemmed Attenuation of Vanadium-Induced Neurotoxicity in Rat Hippocampal Slices (In Vitro) and Mice (In Vivo) by ZA-II-05, a Novel NMDA-Receptor Antagonist
title_short Attenuation of Vanadium-Induced Neurotoxicity in Rat Hippocampal Slices (In Vitro) and Mice (In Vivo) by ZA-II-05, a Novel NMDA-Receptor Antagonist
title_sort attenuation of vanadium induced neurotoxicity in rat hippocampal slices in vitro and mice in vivo by za ii 05 a novel nmda receptor antagonist
topic Alzheimer’s disease
vanadium
NMDA-receptor antagonist
neurotoxicity
hippocampus
url https://www.mdpi.com/1422-0067/24/23/16710
work_keys_str_mv AT amanydigalladagu attenuationofvanadiuminducedneurotoxicityinrathippocampalslicesinvitroandmiceinvivobyzaii05anovelnmdareceptorantagonist
AT funmilayoeniolaolopade attenuationofvanadiuminducedneurotoxicityinrathippocampalslicesinvitroandmiceinvivobyzaii05anovelnmdareceptorantagonist
AT paulchazot attenuationofvanadiuminducedneurotoxicityinrathippocampalslicesinvitroandmiceinvivobyzaii05anovelnmdareceptorantagonist
AT ademolaaoyagbemi attenuationofvanadiuminducedneurotoxicityinrathippocampalslicesinvitroandmiceinvivobyzaii05anovelnmdareceptorantagonist
AT samuelohiomokhare attenuationofvanadiuminducedneurotoxicityinrathippocampalslicesinvitroandmiceinvivobyzaii05anovelnmdareceptorantagonist
AT oluwabusayorachealfolarin attenuationofvanadiuminducedneurotoxicityinrathippocampalslicesinvitroandmiceinvivobyzaii05anovelnmdareceptorantagonist
AT taidindatasharagilbert attenuationofvanadiuminducedneurotoxicityinrathippocampalslicesinvitroandmiceinvivobyzaii05anovelnmdareceptorantagonist
AT madisonfuller attenuationofvanadiuminducedneurotoxicityinrathippocampalslicesinvitroandmiceinvivobyzaii05anovelnmdareceptorantagonist
AT toanluong attenuationofvanadiuminducedneurotoxicityinrathippocampalslicesinvitroandmiceinvivobyzaii05anovelnmdareceptorantagonist
AT adeboyeadejare attenuationofvanadiuminducedneurotoxicityinrathippocampalslicesinvitroandmiceinvivobyzaii05anovelnmdareceptorantagonist
AT jamesoolopade attenuationofvanadiuminducedneurotoxicityinrathippocampalslicesinvitroandmiceinvivobyzaii05anovelnmdareceptorantagonist